Related by context. Frequent words. (Click for all words.) 75 Epratuzumab 74 Nexavar ® 74 Alemtuzumab 73 multi kinase inhibitor 73 Apixaban 72 Pirfenidone 72 Mipomersen 72 R sorafenib tablets 71 elotuzumab 71 Amrubicin 71 Vandetanib 71 relapsing multiple sclerosis 71 KRN# 70 Panzem R 70 Bavituximab 70 Bortezomib 70 phase IIb clinical 70 Cethromycin 70 Onalta 69 daclizumab 69 metastatic hormone refractory 69 humanized monoclonal antibody 69 Ofatumumab 69 liposomal formulation 69 Voreloxin 69 hepatitis C HCV 69 mTOR inhibitor 69 Traficet EN 68 Pivotal Phase III 68 KNS # 68 PEG SN# 68 Phase Ib clinical 68 Laquinimod 68 Everolimus 68 Irinotecan 68 Perifosine 68 EndoTAG TM -1 68 pertuzumab 68 Carfilzomib 68 drug conjugate 68 OncoVEX GM CSF 68 Pivotal Phase 68 orally bioavailable 68 Clevudine 68 Drug Candidate 68 Allovectin 7 R 68 Zolinza 68 PARP inhibitor 67 Dasatinib 67 relapsed multiple myeloma 67 BAY #-# 67 Elesclomol 67 PEG Interferon lambda 67 Pulmonary Arterial Hypertension 67 registrational trial 67 Panitumumab 67 Azedra 67 Eltrombopag 67 Phase III Clinical Trial 67 Bevacizumab 67 Erlotinib 67 ocrelizumab 67 Phase III Trial 67 Rituximab 66 humanized antibody 66 Clinical Trial Results 66 humanized anti 66 atacicept 66 antisense drug 66 Gemzar ® 66 ANYARA 66 Lenalidomide 66 Bicifadine 66 Herceptin trastuzumab 66 Rebif ® 66 BrachySil 66 DDP# 66 Pivotal Trial 66 phase IIa 66 Sym# 66 Icatibant 66 pseudobulbar affect PBA 66 Hepatitis C HCV 66 Patient Enrollment 66 ATL# [001] 66 GV# [001] 66 HCV protease inhibitor 66 Satraplatin 66 CCX# 65 Naproxcinod 65 Natalizumab 65 CYC# 65 Torisel 65 BMS # 65 phase IIb 65 Crofelemer 65 relapsed refractory multiple myeloma 65 MEK inhibitor 65 LymphoStat B 65 Diamyd ® 65 Benign Prostatic Hyperplasia